CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

100 hedge funds and large institutions have $211M invested in Cascadian Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.99M
Puts
$1.74M
Net Calls
Net Calls Change

Top Sellers

1 -$17.1M
2 -$14.4M
3 -$6.73M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.37M
5
First Eagle Investment Management
First Eagle Investment Management
New York
-$2.12M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$36.5M
2
$28.3M
3
$21M
4
$15.6M
5
$13M
6
$12.5M
7
$11.9M
8
$9.82M
9
$6.36M
10
$5.27M
11
$4.14M
12
$3.64M
13
$2.51M
14
$2.25M
15
$2.15M
16
$2.04M
17
$1.99M
18
$1.93M
19
$1.77M
20
$1.75M
21
$1.53M
22
$1.51M
23
$1.38M
24
$1.35M
25
$1.14M